Central Composite Design Tool Application for Optimizing Methanolic Leaves Extract of Ceiba Pentandra L. Ethosome Suspension Gel with InSilico, In Vitro, and In Vivo Anti-inflammatory Effects

Introduction: The goal of this research is to develop a gel formulation from the leaf extract of Ceiba pentandra L. and to evaluate its anti-inflammatory properties using in silico, in vitro, and in vivo approaches. The in silico anti-inflammatory effects of the gel were validated by in vitro and in vivo studies. Methods: A Central Composite Design (CCD) was applied to optimize the extract suspension. Anti-inflammatory activity has been compared with Indomethacin molecules in PDB ID:4IK7. Further, absorption, distribution, metabolism, excretion, and toxicity analysis have been performed to ensure the therapeutic potential and its safety for the drug development process. Results: The extracted gel has been characterized by performing Fourier transformer infrared, zeta potential, particle size, scanning electron microscope, and entrapment efficiency. Furthermore, the formulation was evaluated by assessing its viscosity, spreadability, and pH. Discussion: An in vitro study of all nine extract suspensions was conducted to determine the drug content at 295 nm. The optimized suspension has shown the maximum percentage of drug release (83.43%) in 09 hours of study. Anti-inflammatory effects of extract and gel are studied by animal studies using formalin to induce paw inflammation. result: The optimized suspension has shown the maximum percentage of drug release (83.43%) in 09 hours of study. Anti-inflammatory effects of extract and gel are studied by animal study using formalin to induce paw inflammation. Conclusion: The results of the study conclude that the gel formulation exhibits stronger antiinflammatory activity compared to the extract, and molecular docking studies support the therapeutic potential of the extract’s bioactive molecules. ADMET analysis ensures the therapeutic effects and its safety.